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ABSTRACT
Excessive production of Ab (amyloid b-peptide) has been
shown to play an important role in the pathogenesis of AD
(Alzheimer’s disease). Although not yet well understood,
aggregation of Ab is known to cause toxicity to neurons. Our
recent study demonstrated the ability for oligomeric Ab to
stimulate the production of ROS (reactive oxygen species) in
neurons through an NMDA (N-methyl-D-aspartate)-dependent
pathway. However, whether prolonged exposure of neurons to
aggregated Ab is associated with impairment of NMDA
receptor function has not been extensively investigated. In
the present study, we show that prolonged exposure of primary
cortical neurons to Ab oligomers caused mitochondrial
dysfunction, an attenuation of NMDA receptor-mediated
Ca
2+ influx and inhibition of NMDA-induced AA (arachidonic
acid) release. Mitochondrial dysfunction and the decrease in
NMDA receptor activity due to oligomeric Ab are associated
with an increase in ROS production. Gp91ds-tat, a specific
peptide inhibitor of NADPH oxidase, and Mn(III)-tetrakis(4-
benzoic acid)-porphyrin chloride, an ROS scavenger, effectively
abrogated Ab-induced ROS production. Furthermore, Ab-
induced mitochondrial dysfunction, impairment of NMDA
Ca
2+ influx and ROS production were prevented by pre-
treatment of neurons with EGCG [(2)-epigallocatechin-3-
gallate], a major polyphenolic component of green tea. Taken
together, these results support a role for NADPH oxidase-
m e d i a t e dR O Sp r o d u c t i o ni nt h ec y t o t o x i ce f f e c t so fA b,a n d
demonstrate the therapeutic potential of EGCG and other
dietary polyphenols in delaying onset or retarding the
progression of AD.
Key words: arachidonic acid (AA) release, Ca
2+ influx,
(2)-epigallocatechin-3-gallate (EGCG), NADPH oxidase,
N-methyl-D-aspartate (NMDA) receptor, oligomeric Ab,
reactive oxygen species (ROS).
INTRODUCTION
AD (Alzheimer’s disease) is the most prevalent form of
dementia affecting over 5.3 million people in the U.S.A.
(Alzheimer’s Association 2010), and 35 million worldwide
(World Health Organization). With the disproportional
increase in the ageing population in the next decade, these
1To whom correspondence should be addressed (email sung@missouri.edu).
Abbreviations: AA, arachidonic acid; Ab, amyloid b-peptide; ACSF, artificial cerebrospinal fluid; AD, Alzheimer’s disease; BCS, bovine calf serum; cPLA2,c y t o s o l i c
phospholipase A2; DHE, dihydroethidium; DMEM, Dulbecco’s modified Eagle’s medium; EGCG, (2)-epigallocatechin-3-gallate; ERK1/2, extracellular-signal-regulated
kinase 1/2; LDH, lactate dehydrogenase; MAPK, mitogen-activated protein kinase; MnTBAP, Mn(III)-tetrakis(4-benzoic acid)-porphyrin chloride; MTT, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide; NMDA, N-methyl-D-aspartate; ROS, reactive oxygen species; TBS-T, Tris-buffered saline, pH 7.4, with 0.5%
Tween 20.
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asnneuro.org / Volume 3 (1) / art:e00050 13numbers are likely to double by 2050. Although the progressive
deterioration in memory and cognitive functions in AD is
marked by an increase in neuronal loss and synaptic
impairment in specific regions of the brain (Selkoe, 2002), the
molecular mechanisms leading to the pathogenesis of
the disease are still not well understood (Querfurth and
LaFerla, 2010). Recent studies have recognized the ability of Ab
(amyloid b-peptide) to aggregate into oligomeric form and
induce toxicity in neurons (Shankar et al., 2007; Walsh
and Selkoe, 2007; Palop and Mucke, 2010). However,
understanding the mechanisms whereby Ab oligomers impair
synaptic function remains elusive.
High oxygen consumption in the brain is associated with
oxidative stress, and overproduction of ROS (reactive oxygen
species) is known to play an important role in the cytotoxic
effects of Ab (Butterfield et al., 2001; Sultana and Butterfield,
2010). Recent studies have demonstrated NADPH oxidase, the
superoxide producing enzyme, as an important source of ROS
production in brain cells (Sorce and Krause, 2009). Activation
of NADPH oxidase is linked to excitotoxity mediated by the
ionotropic glutamate receptors (Kishida et al., 2005; Brennan
et al., 2009). Our studies further show that Ab can also
enhance ROS production in neurons via the NMDA (N-
methyl-D-aspartate) receptor-dependent NADPH oxidase
pathway. In turn, this receptor activation and ROS production
can lead to activation of downstream signalling pathway for
MAPKs (mitogen-activated protein kinases) and cPLA2
(cytosolic phospholipase A2) (Shelat et al., 2008). Although
the involvement in Ab-induced neuronal dysfunction that
underlies the progression of AD has not been fully
investigated, there is evidence for involvement of NADPH
oxidase activity in oxidative and inflammatory responses in a
number of neurodegenerative diseases (Sun et al., 2007).
Despite the increasing recognition of a link between oli-
gomeric Ab and NMDA receptor function, the extent of
neuronal damage due to prolonged exposure of neurons to
this toxic form of Ab has not been investigated in detail. In
the present study, we investigated the effects of oligomeric
Ab on rat primary cortical neurons and determined that
prolonged exposure of neurons to oligomeric Ab led to
accumulation of NADPH oxidase-dependent ROS production,
and in turn mitochondrial dysfunction, NMDA receptor-
mediated Ca
2+ influx and AA (arachidonic acid) release. We
further demonstrated that EGCG [(2)-epigallocatechin-3-
gallate], a major polyphenol from green tea, can protect
neurons from the cytotoxic effects of oligomeric Ab.
MATERIALS AND METHODS
Materials
DMEM (Dulbecco’s modified Eagle’s medium), Neurobasal
medium, Pen/Strep, B27-AO (B27 without antioxidants),
L-glutamine, Hepes, Ham’s F-12 medium, 106Hanks buffer,
Fluo-4 AM, AlarmaBlue
TM and trypsin-EDTA were obtained
from Invitrogen (Carlsbad, CA, U.S.A.). BCS (bovine calf
serum) was purchased from Hyclone (Thermo Fisher Scientific,
South Logan, UT, U.S.A.). DHE (dihydroethidium), NMDA,
resveratrol, EGCG, poly-L-lysine, BSA and nimopridine were
purchased from Sigma–Aldrich (St. Louis, MO, U.S.A.).
[1-
14C]AA (specific activity 50 mCi/mmol) was obtained from
NEN (Boston, MA, U.S.A.). Ab (Ab1-42 and Ab 42-1) was
purchased from American Peptide Co. (Sunnyvale, CA, U.S.A.).
MnTBAP [Mn(III)-tetrakis(4-benzoic acid)-porphyrin chloride]
was obtained from EMD Chemicals Inc. (Darmstadt,
Germany). The NADPH oxidase inhibitor, gp91ds-tat peptide
that specifically targets the gp91 docking site, was originally
designed by the Pagano group (Rey et al., 2001) and was
synthesized by Anaspec (San Jose, CA, U.S.A.).
Primary cortical neuron cultures
Primary cortical neurons were prepared from fetal brain of
Sprague–Dawley rats at E17 (embryonic day 17) using the
instructions described previously (Shelat et al., 2008) with
slight modifications. In brief, cerebral cortices were dissected
in Hanks buffer followed by incubation with 0.05% trypsin
(GIBCO, Grand Island, NY, U.S.A.) at 37˚C for 45 min. The
cortices were mechanically dispersed with a pasture pipette.
The cell pellet was re-suspended in D10C medium (DMEM
including 10% BCS, 10% Ham’s F-12 medium, 2 mM L-
glutamine, 2.5% Hepes and 0.25% Pen/Strep). Cells (1.3610
5/
cm
2) were seeded into 50 mg/l poly-L-lysine-coated plates or
dishes in D10C medium. After 4–5 h, the D10C medium was
replaced with Neurobasal medium containing 2% B27-AO, 2
mM L-glutamine and1% Pen/Strep.Cells wereculturedat 37˚C
in a humidified incubator with 5% CO2 for at least 8 days
before experiments, and half of the medium was replaced with
fresh medium every 3–4 days. Immunostaining for specific
markers of astrocytes [GFAP (glial fibrillary acidic protein)],
microglia (OX-42) and neurons [MAP-2 (microtubule-assoc-
iated protein-2)] indicated that the 8-day-old neuronal
cultures contained only 3–4% astrocytes and 3% microglia
(Shelat et al., 2008). Neuronal morphology was routinely
visualized using an inverted microscope from Olympus (Center
Valley, PA, U.S.A.) with a 620 objective. Experiments were
carried out according to the guidelines set forth by the NIH
Guide for the Care and Use of Laboratory Animals.
Preparation and characterization of Ab
Preparation of oligomeric Ab
Oligomeric Ab, referred to as Ab1-42, was prepared as
described (Dahlgren et al., 2002). Briefly, purified Abs
(America Peptide) were dissolved in HFIIP (1,1,1,3,3,3-
hexafluoro-2-propanol) to allow full conversion into the
monomeric form. The monomeric Ab was divided into
aliquots into Eppendorf tubes and the organic solvent was
evaporated using a speed vacuum apparatus (Savant, Fisher
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280˚C until used. To obtain oligomeric Ab, samples in the
Eppendorf tubes were dissolved in DMSO to make a
concentration of 5 mM, followed by sonication for 30 s.
The suspension was diluted with PBS (pH 7.4) to 0.1 mM Ab,
and the samples were then incubated at 4˚C for 24 h. As a
control, Ab42-1 was treated similarly to Ab1-42.
Analysis of oligomeric Ab species
Samples were mixed with 26Tris-tricine buffer (Bio-Rad,
Hercules, CA, U.S.A.) and resolved in a 16% Tris-tricine gel.
After electrophoresis, samples were transferred to PVDF
membrane with a 200 mA current at 4˚Cf o r2h .T h em e m b r a n e
was incubated with 5% non-fat milk in TBS-T (Tris-buffered
saline, pH 7.4, with 0.5% Tween 20) at room temperature (25˚C)
for 1 h. The blot was then reacted with antibodies for Ab,6 E 1 0
(1:1000; Covance, CA, U.S.A.), overnight at 4˚C. After washing
three times with TBS-T, the membrane was incubated with goat
anti-mouse IgG-horseradish peroxidase (1:5000; Sigma–Aldrich)
for 1 h at room temperature, and further washed three times
with TBS-T. Immunolabelling was detected by chemilumin-
escence (SuperSignal West Pico, Pierce, Rockford, IL, U.S.A.).
Methods for assessing neuronal viability
Assessment of mitochondrial function
Mitochondrial dysfunction is an initial step in apoptotic
pathways that lead toneuronalcell death. Inthepresent study,
mitochondrialfunctionwasassessedbytheabilityofreductase
in neurons to reduce MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-2H-tetrazolium bromide; Sigma–Aldrich]. In brief,
primary cortical neuron cultures in 24-well plates were treated
with Ab and/or inhibitors at 37˚C for different times. After
treatment, the culture medium was replaced by 500 mlo f
neurobasal medium with 0.5 mg/ml MTT, and further
incubated at 37˚C for 3 h. After removing the MTT solution,
the remaining formazan crystals were dissolved in 500 mlo f
DMSO. After shakingthe plates at roomtemperature for 5 min,
absorbance was read at 540 nm using a Syn4 Plate Reader
(BioTekInstruments, Inc, Fisher Scientific, St. Louis, MO,U.S.A.).
Assessment of neuronal membrane integrity
The release of the soluble enzyme, LDH (lactate dehydrogen-
ase), from cells into the culture medium is an indication of
loss of membrane integrity. In this assay, neurons were
cultured in 24-well plates and treated with 1 mMA b at 37˚C
for 24 h. After treatment, an aliquot of the culture medium
was collected and LDH activity was measured using the LDH
kit (Roche, Indianapolis, IN, U.S.A.).
AlamarBlue assay
AlamarBlue
TM (Invitrogen) is a cell permeable non-fluorescent
dye,whichcanbe convertedinto to red fluorescence viareductive
reactions within live cells. This assay is used to determine the
extent of cell viability in cultures after various treatments. Briefly,
neurons were cultured in 24-well plates for 9 days and then
treated with or without 1 mMA b at 37˚C for 24 h. After
treatments, 100 mlo fA l a m a r B l u e
TM was added to each well and
neurons were further incubated at 37˚C for 3–4 h. Absorbance
was read at 570 nm with measurement at 600 nm as a reference.
Determination of NMDA-induced Ca
2+ influx
NMDA-induced Ca
2+ influx in neurons was determined using
the calcium fluorescent dye, Fluo-4 AM, and performed
according to the instructions described previously (Ding et al.,
2009). Briefly, neurons were cultured on 12 mm coverslips for
9–10 days. Before stimulation with NMDA, neurons were
treated with or without 1 mMA b and/or 10 mM EGCG or 1
mM gp91ds-tat for 30 min or 16 h. After pre-treatment, cells
were incubated at room temperature (in the dark) with 1 mM
Fluo-4 AM for 30 min in ACSF (artificial cerebrospinal fluid)
medium (125 mM NaCl, 10 mM Hepes, 5 mM KCl, 3.1 mM
CaCl2, 1.3 mM MgCl2 and 10 mM glucose, pH 7.4). Cells were
then transferred to a flow through a chamber fitted within
the microscope. Time-lapse Ca
2+ imaging was performed
using an upright wide-field epi-fluorescence microscope (FN1
system, Nikon) with a 640/0.8 water immersion objective.
Excitation was generated with an X-Ford metal halide lamp
filtered with a fluo-4 filter cube. Emission was detected by a
CoolSNAP-EZ CCD-camera (Photometrics, AZ, U.S.A.). After
perfusion to obtain the base-line results, 50 mM NMDA was
applied in ACSF medium without MgCl2 but with 1 mM
nimopridine, a selective antagonist of the L-voltage-sensitive
calcium channel (Ho et al., 2001; Ueda et al., 1997). The
perfusion system was equipped with a pinch valve that
controls the duration of the application. After exposing
neurons to NMDA for 30 s, cells were perfused again with the
ACSF medium with MgCl2 (1.3 mM). During perfusion, images
of neurons were acquired using the Metamorph software
(Molecular Devices, Sunnyvale, CA, U.S.A.) at 2 s intervals for
2 min (a total of 61 frames were obtained). Each treatment
condition was performed in triplicate and three random fields
were recorded. Results were exported using the Metamorph
software to generate background-subtracted images. The
magnitude of the Ca
2+ signal was defined as the average of
DF/F0 from each cell and the area under the curve for NMDA
stimulation and ACSF washout was determined using the
GraphPad Prism Software (GraphPad Prism Software Inc., San
Diego, CA, U.S.A.). At least 100 cells were selected to obtain
the average area for each group.
Measurement of ROS production
ROS production in primary cortical neurons was assayed using
DHE. Oxidation of DHE by superoxide anions produces
fluorescent ethidium, which is intercalated into DNA
(Chapman et al., 2005). Therefore ROS production can be
quantified by measuring the fluorescence intensity of ethidium
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15in cells. In brief, neurons were cultured (to 70% confluence) on
35 mm dishes coated with 50 mg/l poly-L-lysine. Neurons were
then treated with Ab, EGCG, gp91ds-tat or MnTBAP for 30 min
or 16 h in neurobasal medium without Phenol Red but with 0.5
mg/ml BSA. At 30 min before image acquisition, cells were
loaded with 10 mM DHE and incubated at 37˚C. Fluorescence
images were acquired using a Nikon TE-2000 U inverted
microscope with a 620 NA 0.95 objective and a cooled CCD
camera controlled with a computer running the MetaView
imaging software (Universal Imaging, West Chester, PA, U.S.A.).
The fluorescence excitation source was controlled with a Uni-
Blitz mechanical shutter. For image acquisition, a short exposure
time (200 ms) and low-intensity excitation light were applied to
minimize photo-bleaching. Digital images were analysed using
the MetaView softwarewithautomaticbackground subtraction.
Threshold fluorescence was obtained for each image before the
quantification. For each field, the total fluorescence was
measured and expressed as average fluorescence versus total
number of cells (recorded as bright field image). For each
treatmentgroup,threerandomimagesfromthesamefieldwere
taken and analysed, and each treatment was repeated three
times independently for statistical analysis.
Measurement of AA release
Measurement of AA release was performed essentially as
previously described (Xu et al., 2002; Shelat et al., 2008) with
minor modifications. Briefly, primary cortical neurons in a 35-
mm dish were treated with or without 1 mMA b for different
times (0, 4, 12 and 24 h) at 37˚Ca n d0 . 1mCi of [1-
14C]AA was
addedfor the final 4 h. Thistime issufficient for more than 75%
of the [1-
14C]AA to be incorporated into membrane phospho-
lipids (Xu et al., 2002). After incubation, excess free [1-
14C]AA in
the cells and medium was removed by three successive washes
with buffer A containing 145 mM NaCl, 5.5 mM KCl, 1.1 mM
MgC12,1 . 1m MC a C 1 2, 5.5 mM glucose, 20 mM Hepes, pH 7.4
and BSA (0.5 mg/ml). The phospholipid-labelled neurons were
stimulated with 100 mMN M D Aa t3 7 ˚Cf o r3 0m i n ,a n dt h e
release of [1-
14C]AA into the culture medium was determined
with a Beckman LS 5800 liquid scintillation counter (Fullerton,
CA, U.S.A.). Radioactivity remaining in the cells was also
determined by adding 2 ml of methanol to the dish and
harvesting the cells using a scraper. Net radioactivity released
into the culture medium in response to NMDA was obtained by
subtracting the background radioactivity released from cells
incubated in the absence of NMDA. Labelled AA released from
neurons treated with Ab for different time periods and
subsequently subjected to a 30-min stimulation with NMDA
were expressed as percentages of the total radioactivity in
labelled cells, i.e. radioactivity released into the medium over 30
min plus radioactivity remaining in the cells.
Statistical analysis
The results were analysed either by one-way or two-way
ANOVA followed by Bonferroni’s multiple comparison tests
(V4.00, GraphPad Prism Software, Inc, San Diego, CA, U.S.A.).
Values of P,0.05 were considered significant.
RESULTS
Prolonged exposure of neurons to oligomeric Ab
induces mitochondrial dysfunction but not
neuronal cell death
In the present study, we prepared oligomeric Ab according to
the instructions described by LaDu’s group (Dahlgren et al.,
2002). Western-blot analysis of the preparation showed the
presence of monomers, trimers and tetramers, but no obvious
dimers or higher-molecular mass oligomers (Figure 1A). To test
whether the time of Ab aggregation affects neuronal toxicity,
Ab was aggregated at 4˚C for 0, 4, 12 or 24 h before exposure
to rat primary cortical neurons and further incubation at 37˚C
for 24 h. Results in Figure 1(B) show a time-dependent
decrease in mitochondrial function (i.e. MTT reduction) with
increase in time of Ab aggregation. Significant decrease in MTT
was observed after exposing neurons to Ab (1 mM) that was
aggregated for 12 (P,0.05) and 24 h (P,0.001).
Following the study with MTT reduction to access mito-
chondrial function, we also determined whether exposure of
neurons to oligomeric Ab (1 mM) is associated with an increase
in cell death. LDH release was used to determine loss of
membrane integrity, and AlamarBlue
TM assay was used to
determine neuronal viability. As shown in Figures 1(C) and
1(D), incubation of neurons with oligomeric Ab (1 mM) for 24 h
neither caused an increase in LDH release nor changes in live
cell numbers. These results indicate that despite mitochondrial
dysfunction, Ab-treated neurons remain viable.
The specificity for Ab1-42 for mediating mitochondrial
dysfunction was tested by comparing with the reverse peptide,
Ab 42-1, which was prepared using the same instruction as Ab1-
42. As shown in Figure 1(E), neurons exposed to Ab42-1 (1 mM)
did not result in mitochondrial dysfunction and MTT levels
were comparable with controls without Ab.
Prolonged exposure of neurons to oligomeric Ab
inhibits NMDA-induced Ca
2+ influx
Since prolonged exposure of neurons to oligomeric Ab resulted
in mitochondrial dysfunction but not cell death, we next
examined whether this form of Ab can alter other neuronal
functions, such as NMDA receptor-mediated Ca
2+ influx. In the
present study, primary cortical neurons were loaded with Fluo-4
AM and perfused with NMDA (50 mM) for 30 s. As shown in
Figure 2(A), NMDA stimulation elicited a rapid and transient
increase in Ca
2+ influx. However, when neurons were exposed to
oligomeric Ab (1 mM) for 16 h before stimulation with NMDA, a
significant decrease (57%, P,0.05) in Ca
2+ influx was observed
H Yan and others
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of NMDA stimulation also showed a decrease in fluorescence
between neurons pre-treated with Ab for 16 h as compared to
controls (Figure 2B). As a negative control, neurons treated with
Ab42-1 (1 mM) for 16 h exhibited no significant changes in
NMDA-induced Ca
2+ influx, as compared with untreated
controls (Figure 2C). These results indicate that impairment of
NMDA receptor-mediated Ca
2+ influx is associated with
prolonged exposure of neurons to oligomeric Ab.
Prolonged exposure of neurons to oligomeric Ab
decreases NMDA-induced AA release
We previously reported that Ab causes AA release from neurons
through a signalling pathway involving NMDA receptor, NADPH
oxidase, ERK1/2 (extracellular-signal-regulated kinase 1/2) and
cPLA2 (Shelat et al., 2008). In the present study, we examined the
effect of prolonged exposure of neurons to oligomeric Ab on
NMDA-induced AA release. Cortical neurons were pre-treated
with or without Ab(1 mM) for different time periods (0–24 h) and
labelled with [1-
14C]AA for the final 4 h before stimulation with
NMDA (100 mM) for 30 min. As shown in Figure 3, a significant
(P,0.05) decrease in the NMDA-induced AA release from
prelabelled-phospholipids was observed on exposure of neurons
to oligomeric Ab for 12 or 24 h. As a negative control, no obvious
decrease in AA release was observed on incubation of neurons
with the reverse peptide (Ab42-1) (results not shown). These results
are consistent with results in Figure 2 showing that prolonged Ab
exposure to neurons inhibited NMDA-stimulated Ca
2+ influx.
Prolonged exposure of neurons to Ab increases
ROS production
In our earlier study, although NMDA (100 mM) could cause a
robust increase in ROS production in neurons, the amount of
ROS produced by Ab (1-5 mM) was very low (Shelat et al.,
2008). In this next set of experiments, we determined levels of
ROS in neurons after prolonged exposure to Ab. As shown in
Figure 1 Neuronal toxicity of oligomeric Ab
Oligomeric Ab was prepared as indicated in the Materials and methods section. (A) The sample from a typical preparation was analysed
byWestern blotshowing thepresence oftrimers and tetramers aswell asmonomers afteraggregation inPBS at4˚C for24h.Positionsof
molecularmass markersareshown onthe leftinkDa. (B)A bwas aggregatedfordifferenttime periods (0, 4,12and 24h)at4˚C and then
1 mM was incubated with rat primary cortical neurons for 24 h. Results depict mitochondrial function using the MTT assay. (C) Neurons
were treated with or without Ab (1 mM) for 24 h followed by assay of LDH release as an indication of a loss in membrane integrity. (D)
Neurons were treated with or without oligomeric Ab (1 mM) for 24 h and neuronal viability was determined using the AlarmaBlue
TM
assay. (E) Rat primary cortical neurons were incubatedwithorwithoutoligomericAb1-42(1mM)orAb42-1(1mM)fo r0,8,16or24h,an d
mitochondrial function was measured using the MTT assay. Results are mean¡S.E.M. values for three independent experiments and are
analysed by one-way ANOVA followed by Bonferroni’s multiple comparison tests.*P,0.05 and ***P,0.001, as compared with control.
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17Figures 4(A) and 4(B), a significant increase (P,0.01) in ROS
productionwasfoundinneuronsonexposuretooligomeric Ab
(1 mM) for 16 h. Examination of neurons under the bright field
microscope indicated that neuronal morphology was preserved
after prolonged exposure to Ab (Figure 4A).
Gp91ds-tat protects neurons from prolonged Ab-
induced ROS production, mitochondrial dysfunction
and inhibition of NMDA-mediated Ca
2+ influx
Since prolonged exposure of neurons to oligomeric Ab is
associated with ROS accumulation, we subsequently evalu-
ated the source of ROS using the cell permeable NADPH
oxidase peptide inhibitor, gp91ds-tat. Results in Figure 5(A)
show that ROS accumulation due to prolonged exposure
of Ab (1 mM) was completely inhibited by pre-treatment of
neurons with gp91ds-tat (1 mM). These results suggest that
NADPH oxidase is the primary source of ROS in neurons
induced by Ab.
We further tested whether gp91ds-tat can protect neurons
from the toxic effects of prolonged exposure to oligomeric
Ab. As shown in Figure 5(B), pre-treatment of neurons with
gp91ds-tat completely prevented Ab-induced mitochondrial
dysfunction. Pretreatment with gp91ds-tat also protected
neurons from Ab-induced inhibition of NMDA receptor-
mediated Ca
2+ influx (Figure 5C).
Figure 2 Prolonged exposure of neurons to Ab impairs NMDA receptor-mediated Ca
2+ influx
Primary cortical neurons were cultured on coverslips and exposed to oligomeric Ab1-42 (1 mM) or Ab42-1 (1 mM) for 16 h. Neurons
were labelled with Fluo-4-AM for 30 min before stimulation with NMDA (50 mM) for 30 s in ACSF medium containing nimopridine (1
mM) without Mg
2+, and then followed by perfusion with ACSF medium with Mg
2+. Average fluorescence of Fluo-4 was measured as
described in the Materials and methods section. (A) Representative curves depicting NMDA-induced Ca
2+ influx with or without
oligomeric Ab for 16 h. (B) Representative fluorescent images of neurons taken before and during (30 s) NMDA stimulation. (C)B a r
graphs to depict NMDA-induced Ca
2+ influx as determined by calculating the area under the curve using the GraphPad Prism
Software 4. Results are means¡S.E.M. for three independent experiments and are analysed by one-way ANOVA followed by
Bonferroni’s multiple comparison tests.* P,0.05, as compared with control.
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effects of Ab
Since inhibitors of NADPH oxidase-mediated ROS production
can protect neurons from the toxic effects of Ab,i ti s
reasonable that other natural antioxidants may also inhibit
Ab-induce neurotoxicity. Therefore our experiment was
extended to testing botanical polyphenols known to possess
anti-oxidative properties. Results show that exposing neurons
to EGCG (10 mM), an antioxidant from green tea, completely
prevented mitochondrial dysfunction induced by 1 mMA b
(Figure 6A). Incubation of neurons for 16 h with EGCG alone
(up to 100 mM) had no effect on mitochondrial function
(results not shown). Albeit not as effective as EGCG,
resveratrol (25–50 mM), another polyphenol enriched in
grapes, could also inhibit Ab-induced mitochondrial dysfunc-
tion in neurons (results not shown).
Since prolonged exposure of neurons to Ab resulted in
inhibition of NMDA-induced Ca
2+ influx (Figure 2), we
further tested whether pre-treatment of neurons with
EGCG could prevent this deleterious effect. As shown in
Figure 6(B), pre-treatment of neurons with 10 mM EGCG
completely blocked the inhibition of NMDA-induced Ca
2+
influx caused by prolonged exposure to 1 mMA b for 16 h.
EGCG alone exerted no significant effect on NMDA-induced
Ca
2+ influx, as compared to untreated control (Figure 6B).
Results in Figure 4 demonstratedthat prolonged Ab exposure
causedROSaccumulationinneurons.Itwasthereforeimportant
to determine whether EGCG may play a role in inhibiting
Ab-mediated ROS production. Figure 6(C) showed that pre-
treatment with EGCG (10 mM) before exposing neurons to Ab (1
mM) for 16 h completely prevented Ab-induced ROS pro-
duction. As a positive control, MnTBAP (20 mM), a compound
widely used as an SOD (superoxide dismutase) mimetic (Carvour
et al., 2008) and ROS scavenger (Dietrich et al., 2010), also
inhibited ROS production induced by Ab exposure for 16 h
(Figure 6C). On the other hand, neither EGCG nor MnTBAP alone
could alter basal ROS levels in neurons (Figure 6C).
DISCUSSION
DespitethefactthatADwasdiscoveredover100yearsago,the
pathogenesis of the disease is still not well understood and
Figure 3 Prolonged exposure of neurons to Ab inhibits NMDA receptor-
mediated AA release
Neurons were treated with Ab (1 mM) for 0, 4, 12 and 24 h, and subsequently
labelled with [1-
14C]AA for the final 4 h. After removing free [1-
14C]AA,
neurons were stimulated with NMDA (100 mM) for 30 min and [1-
14C]AA re-
lease from phospholipids into the medium was measured after subtracting
background release. Results are means¡S.E.M. for three independent
experiments and are analysed by one-way ANOVA followed by Bonferroni’s
multiple comparison tests; *P,0.05 and **P,0.01, as compared with control.
Figure 4 Prolonged exposure to Ab induces ROS accumulation in neurons
(A) Neurons were pre-treated with Ab (1 mM) for 30 min or 16 h, and then loaded with DHE. In each field, DHE fluorescent neurons
and the corresponding bright field images were recorded. (B) Average fluorescent intensity of neurons was calculated. Results are
means¡S.E.M. for three independent experiments and analysed by one-way ANOVA followed by Bonferroni’s multiple comparison
tests. **P,0.01 as compared with control.
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19effective treatment for the disease remains elusive. Although
many studies in the past regarded amyloid accumulation to be
a pathological landmark of the disease, the ‘amyloid
hypothesis’ has been subjected to challenges (Hardy, 2009). A
major problem regarding this hypothesis is the inability to link
amyloid accumulation to the severity of the disease, and
difficulty in demonstrating toxic forms of Ab in AD brain.
Nevertheless, recent studies have provided convincing
evidence that Ab aggregates, especially when present in the
oligomeric forms, can alter neuronal circuitry and impair
synaptic activity, events that underlie the cognitive decline in
AD (Palop and Mucke, 2010). Work by Shankar’s group further
demonstrated the release of soluble Ab oligomers (mainly
dimers and trimers) from hippocampal slices of AD transgenic
mice, and that low concentrations of the Ab oligomers in the
conditioned media can cause neurotoxic effects and inhibit
NMDA-induced Ca
2+ influx into synaptic spines (Shankar et al.,
2007, 2008). With regard to the presence of Ab oligomers in
the AD brain, a recent study provided strong support for the
progressive accumulation of these toxic forms of Ab with
increasing degree of synaptic loss and severity of cognitive
impairment (Pham et al., 2010). It is obvious that different
types of tissue or cell preparations can produce different pat-
terns of Ab oligomers, leading to different magnitude of
toxicity. In fact, different ratios of Ab1-42 to Ab1-40 can offer
different patterns of aggregation kinetics and elicit different
degrees of neurotoxicity (Kuperstein et al., 2010). In the
present study, aggregation of synthetic Ab using the in-
struction described by LaDu’s group was shown to produce
trimers and tetramers, with no obvious presence of dimers or
higher-molecular-mass oligomers (Dahlgren et al., 2002; Stine
et al., 2003). As discussed in a recent review by Stine et al.
(2010), Ab oligomer aggregation pattern may vary depending
on acidity and the ionic strength of the solvent used (Stine
et al., 2010). In our hands, this instruction for Ab aggregation
has consistently produced oligomers that impair mitochondrial
function in neurons, as demonstrated using the MTT assay.
However, despite the decrease in mitochondrial function,
exposure to 1 mM oligomeric Ab for 24 h did not result in
neuronal cell death or change in membrane integrity
(Figure 1). In line with the progressive nature of AD, it is not
surprising that Ab oligomers produce subtle neurotoxic effects
that progress to full impairment of synaptic plasticity and
cognitive function before cell death (Ronicke et al., 2010).
Several earlier studies have demonstrated the ability of
oligomeric Ab to exert cytotoxic effects on neurons. Ab was
showntosuppressNMDA-inducedcurrentsincortical neurons,
and this effect was attributed in part to alteration of signalling
pathways leading to endocytosis of NMDA receptors (Snyder
et al., 2005). Other studies showed an interaction between
oligomeric Ab and the NMDA receptor trafficking pathway in
neurons, and in turn resulting in alterations of intracellular
Ca
2+ homoeostasis (Walsh and Selkoe, 2007). Ab oligomers can
cause Ca
2+ influx due to stimulation of NMDA and AMPA
(a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid)
receptors, and this type of glutamate receptor-induced
excitotoxicity can stimulate downstream pathways leading to
mitochondrial membrane dysfunction and neuronal cell death
(Alberdi et al., 2010). Indeed, dysregulation of Ca
2+ homoeo-
stasisisanimportantconsequenceofamyloidtoxicity(Demuro
et al., 2010; Paul and Connor 2010).
Studies in vivo and in vitro have demonstrated that
neuronal excitotoxic events, such as NMDA receptor activa-
tion, are linked to ROS production through activation of
Figure 5 NADPH oxidase inhibitor, gp91ds-tat, inhibits ROS production
and protects neurons against Ab-induced cytotoxicity
(A) Rat primary cortical neurons were treated with gp91ds-tat (1 mM) for 30
min before exposure to Ab (1 mM) for 16 h and followed by ROS determi-
nation as described for Figure 4. Results represent the average fluorescent
intensity of DHE in neurons and are means¡S.E.M. for three independent
experiments. Two-way ANOVA revealed a significant interaction (P50.0072)
and significant effects of Ab (P50.0039) and gp91ds-tat (P50.0180).
Bonferroni post-tests showed a significant difference between control and
Ab (**P,0.01) and between Ab treatment without versus with gp91ds-tat
(^P,0.05). (B) Neurons were treated with gp91ds-tat (1 mM) for 30 min
before exposure to Ab (1 mM) for 16 h followed by the MTT assay. Results are
means¡S.E.M. for three independent experiments. Two-way ANOVA revealed
a significant interaction (P50.0320) and significant effects of Ab (P50.0160)
and gp91ds-tat (P50.0433). Bonferroni post-tests showed a significant
difference between control and Ab (*P,0.05) and between Ab treatment
without versus with gp91ds-tat (^P,0.05). (C) Neurons were incubated with
gp91ds-tat (1 mM) for 30 min before exposure to Ab (1 mM) for 16 h, and
NMDA (50 mM)-induced Ca
2+ influx was determined as described in Figure 2
Results are means¡S.E.M. for three independent experiments. Two-way
ANOVA revealed a significant interaction (P50.0167) and significant effects
of Ab (P50.0095) and gp91ds-tat (P50.0027). Bonferroni post-tests showed
a significant difference between control and Ab (*P,0.05) and between Ab
treatment without versus with gp91ds-tat (ˆˆP,0.01).
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Brennan et al., 2009). In a study with hippocampal slices, ROS
from NADPH oxidase was shown to activate signalling
pathways leading to the activation of ERK1/2 (Serrano et al.,
2009). SinceERK1/2is an important kinase forphosphorylation
of cPLA2, it is reasonable that oligomeric Ab can induce
activation of cPLA2 and the subsequent release of AA (Shelat
et al., 2008). cPLA2 can perturb membrane phospholipids, and
Figure 6 EGCG protects neurons against Ab-induced cytotoxicity
(A) Rat primary cortical neurons were treated with EGCG (10 mM) for 30 min before exposure to Ab (1 mM) for 16 h, and followed by
determination of mitochondrial function using the MTT assay. Results are means¡S.E.M. for three independent experiments.
Two-way ANOVA revealed a significant interaction (P50.0139), and significant effects of Ab (P50.0149) and EGCG (P50.0172).
Bonferroni post-tests showed a significant difference between control and Ab (**P,0.01) and between Ab treatment without versus
with EGCG (^P,0.05). (B) Neurons were incubated with EGCG (10 mM) for 30 min before exposure to Ab (1 mM) for 16 h, followed by
determination of NMDA-induced Ca
2+ influx as described in Figure 2. Analysis by two-way ANOVA revealed a significant interaction
between EGCG and Ab (P50.032), and a significant effect of Ab (P50.027). Bonferroni post tests showed a significant
difference between control and Ab (*P,0.05). (C) Neurons were treated with EGCG (10 mM) or MnTBAP (20 mM) for 30 min before
exposure to Ab (1 mM) for 16 h, followed by determination of ROS as described in Figure 4. Results are means¡S.E.M. for three
independent experiments. Two-way ANOVA revealed a significant interaction between Ab and EGCG (P50.0109), and significant
effects of Ab (P50.0075) and EGCG (P50.0184). A significant interaction between Ab and MnTBAP (P50.0183) was also found.
Bonferroni post-tests showed a significant difference between control and Ab (**P,0.01) and between Ab treatment without versus
with EGCG or MnTBAP (ˆˆP,0.01).
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21besides being a precursor for the synthesis of eicosanoids, AA is
animportantlipidmediatorforregulationofmultiplesignalling
pathways (Bazan, 2003). In the present study, prolonged Ab
exposure to neurons results in the decrease in NMDA receptor
activity and AA release (Figure 3). These results lend further
support to the ability of oligomeric Ab to impair a variety of
neuronal functions (Shi et al., 2010). The ability of oligomeric
Ab to inhibit NMDA receptor function may also be due to a
number of other factors. Besides modulation of receptor
endocytosis (Snyder et al., 2005), there is evidence that Ab may
bind directly to the NMDA receptor subunits (De Felice et al.,
2007; Ronicke et al., 2010). Although the mechanism whereby
prolonged Ab exposure impairs NMDA receptor response is not
yet clearly understood, our results with an gp91ds-tat clearly
demonstrate the important role of NADPH oxidase and ROS in
mediating the damaging effects elicited by Ab.
AD pathology is associated with an increase in mitochondrial
abnormalities and a decrease in ATP production (Hirai et al.,
2001; Moreira et al., 2010). In fact, oxidatively modified proteins
are found in mitochondria (Sultana and Butterfield, 2009), and
increased levels of oxidative stress marker proteins and lipids,
such as protein carbonyls, 3-nitrotyrosine, hydroxynonenal and
isoprostanes, are found in MCI (mild cognitive impairment)
brains (Keller et al., 2005; Mattson, 2009). Whether subunits of
NMDA receptors are particularly susceptible to these oxidative
effects remains to be investigated. Furthermore, despite evidence
for soluble Abto cross the cell membrane and to directly interact
with mitochondrial enzymes, the mechanism underlying mito-
chondrial dysfunction is not yet fully understood (Yan and Stern,
2005; Krafft and Klein, 2010). Studies with neurons and
astrocytes have demonstrated activation of cPLA2 by oligomeric
Ab and, subsequently, this leads to alteration of mitochondrial
membrane (Kriem et al., 2005; Zhu et al., 2006). ROS are small
molecules with important pleiotropic functions. Besides regu-
lating MAPK activity, ROS can perturb membrane lipids and alter
membrane proteins. Therefore the increase in ROS production
due to prolonged exposure of neurons to Abc a nb ea ni m p o r t a n t
underlying mechanism for explaining the oxidative-induced
impairment in synaptic function in AD (Ronicke et al., 2010).
Another important finding from this study is the ability of
botanical antioxidants to protect neurons from the cytotoxic
effects of oligomeric Ab. Our results show that EGCG from
green tea is particularly effective in inhibiting ROS, and
protects neurons from Ab-induced inhibition of NMDA-
stimulated Ca
2+ influx and mitochondrial dysfunction.
Indeed, a number of studies have demonstrated EGCG to elicit
neuroprotective effects (Choi et al., 2001; Kim et al., 2005;
Rezai-Zadeh et al., 2005; Mandel et al., 2006; Kalfon et al.,
2007; Li et al., 2009), and to protect neurons against Ab-
induced toxicity (Bastianetto et al., 2006). EGCG is readily
soluble and can cross the blood–brain barrier (Mandel et al.,
2006). In animal studies, long-term oral administration of
Figure 7 A scheme depicting possible mechanisms for neuronal impairment due to prolonged treatment with Ab and possible sites for
the protective effects of NADPH oxidase inhibitor and EGCG
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SAMP8 (senescence-accelerated mice prone-8) mice could
decrease levelsof Ab in thehippocampus and improve learning
and memory (Li et al., 2009). In cultured hippocampal neurons,
EGCG increased neuronal survival after a 48-h exposure to Ab
and this effect was associated with a decrease in the level of
MDA (malondialdehyde), a marker for lipid peroxidation (Choi
et al., 2001). In our study, EGCG up to 100 mM exerted no toxic
effects in neurons, and 10 mM of EGCG was already sufficient to
protect neurons from Ab-induced neurotoxicity (Figure 5).
Besides inhibition of Ab-induced toxicity, there is evidence
suggesting multiple effects of EGCG, including inhibition of
BACE1 (b-secretase) (Jeon et al., 2003) and aggregation or
remodelling of Ab oligomers (Ono et al., 2003; Bastianetto et al.,
2006). An in vitro study with 7PA2 cells demonstrated that
EGCG can convert Ab oligomers into non-toxic spherical
assemblies (Bieschke et al., 2010). In transgenic mice over-
expressing human APPsw, EGCG increased a-secretase activity
and enhanced the production of non-amyloidogenic APP-a
(amyloid precursor protein-a) as opposed to the cytotoxic Ab
(Rezai-Zadeh et al., 2005). Other studies with endothelial cells
and astrocytes have demonstrated that EGCG inhibits NADPH
oxidase activity (Steffen et al., 2008; Jensen et al., 2009).
In summary, results from this study demonstrated impair-
ment of neuronal function on prolonged exposure to
oligomeric Ab. As shown in Figure 7, short-term exposure of
Ab to neurons can cause excitatory events including activation
of NMDA receptor, increase in Ca
2+ influx, ROS production
and stimulation of signalling pathways leading to the
activation of cPLA2 and AA release (Shelat et al., 2008).
In the present study, we show that more ROS is produced on
prolonged exposure to Ab and this event is accompanied by
impairment of NMDA-mediated Ca
2+ influx and AA release,
and mitochondrial dysfunction (Figure 7). Since ROS produc-
tion on prolonged exposure of neurons to Ab is inhibited
by gp91ds-tat, this study further demonstrates the important
role of NADPH oxidase in producing the ROS that mediates
the cytotoxic effects of Ab. Thus besides providing an
understanding ofthemolecularandcellularpathwayswhereby
oligomeric Ab conveys toxic effects and impairs neuronal
function, this study further opens opportunities to target the
NADPH oxidase pathway to ameliorate the Ab effects. In
the present study, we demonstrate the ability of EGCG to
prevent Ab-induced ROS accumulation and NMDA receptor
dysfunction. These results suggest the possibility for use of
other botanical antioxidants as well as dietary polyphenols for
delaying the onset or retarding the progression of AD.
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